[["Thyroid transcription factor 1 (NKX2-1/TITF1) mutations", "cause", "brain-lung-thyroid syndrome"], ["brain-lung-thyroid syndrome", "is characterized by", "congenital hypothyroidism (CH)"], ["brain-lung-thyroid syndrome", "is characterized by", "infant respiratory distress syndrome (IRDS)"], ["brain-lung-thyroid syndrome", "is characterized by", "benign hereditary chorea (BHC)"], ["the objectives of the study", "were", "detection of NKX2-1 mutations in patients with CH associated with pneumopathy and/or BHC"], ["the objectives of the study", "were", "functional analysis of new mutations in vitro"], ["the objectives of the study", "were", "description of the phenotypic spectrum of brain-lung-thyroid syndrome"], ["three new heterozygous missense mutations", "were identified", "L176V, P202L, Q210P"], ["a splice site mutation", "was identified", "376-2A-->G"], ["one deletion of NKX2-1", "was identified", "at 14q13"], ["functional analysis of the three missense mutations", "revealed", "loss of transactivation capacity on the human thyroglobulin enhancer/promoter"], ["deficient transcriptional activity of NKX2-1-P202L", "was completely rescued by", "cotransfected PAX8-WT"], ["the synergistic effect", "was abolished by", "L176V and Q210P"], ["the clinical spectrum of patients with NKX2-1 mutations", "ranged from", "the complete triad of brain-lung-thyroid syndrome (50%)"], ["the clinical spectrum of patients with NKX2-1 mutations", "ranged from", "brain and thyroid disease (30%)"], ["the clinical spectrum of patients with NKX2-1 mutations", "ranged from", "isolated BHC (13%)"], ["thyroid morphology", "was normal in", "55% of patients"], ["compensated hypothyroidism", "occurred in", "61% of patients"], ["lung disease", "occurred in", "54% of patients"], ["IRDS at term", "occurred in", "76% of patients with lung disease"], ["recurrent pulmonary infections", "occurred in", "24% of patients with lung disease"], ["20% of patients", "developed", "severe chronic interstitial lung disease"], ["16% of patients", "died", "due to lung disease"], ["the study", "describes", "five new NKX2.1 mutations"], ["the study", "shows", "complete rescue by PAX8 of the deficient transactivating capacity in one case"], ["the majority of affected patients", "display", "neurological and/or thyroidal problems"], ["lung disease", "is responsible for", "considerable mortality"]]